Pieris rapae chromosome 12, ilPieRapa1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nLR990594.1.\nAssembly name: ilPieRapa1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Wellcome Sanger Institute on\n2021/01/28. The original whole-genome shotgun project has the\naccession CAJHWY000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris rapae Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
putative protein kinase C delta type homolog, transcript variant X7
COORDINATES: polyA evidence [ECO:0006239]
putative protein kinase C delta type homolog, transcript variant X5
putative protein kinase C delta type homolog, transcript variant X6
putative protein kinase C delta type homolog, transcript variant X2
putative protein kinase C delta type homolog, transcript variant X3
putative protein kinase C delta type homolog, transcript variant X1
putative protein kinase C delta type homolog isoform X7
putative protein kinase C delta type homolog isoform X5
putative protein kinase C delta type homolog isoform X6
uncharacterized protein LOC110995864 isoform X3
probable serine/threonine-protein kinase dyrk2 isoform X2
serine/threonine-protein kinase STE20 isoform X1
putative protein kinase C delta type homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC110995864 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
kelch-like ECH-associated protein 1B, transcript variant X1
kelch-like ECH-associated protein 1B, transcript variant X2
kelch-like ECH-associated protein 1B, transcript variant X3
kelch-like ECH-associated protein 1B, transcript variant X4
kelch-like ECH-associated protein 1B, transcript variant X5
uncharacterized LOC110995877, transcript variant X3
uncharacterized LOC110995877, transcript variant X2
uncharacterized LOC110995877, transcript variant X1
uncharacterized protein LOC110995877 isoform X2
uncharacterized protein LOC110995877 isoform X3
uncharacterized protein LOC110995877 isoform X1
dual specificity protein phosphatase Mpk3, transcript variant X1
dual specificity protein phosphatase Mpk3, transcript variant X2
dual specificity protein phosphatase Mpk3 isoform X1
dual specificity protein phosphatase Mpk3 isoform X2
vacuolar protein sorting-associated protein VTA1 homolog
Golgi-associated PDZ and coiled-coil motif-containing protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Golgi-associated PDZ and coiled-coil motif-containing protein, transcript variant X1
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X1
Golgi-associated PDZ and coiled-coil motif-containing protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X2
uncharacterized LOC110995884, transcript variant X1
uncharacterized protein LOC110995884 isoform X1
uncharacterized LOC110995884, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC110995884 isoform X2
SH3 domain-binding glutamic acid-rich protein homolog
ceramide phosphoethanolamine synthase, transcript variant X1
ceramide phosphoethanolamine synthase, transcript variant X2
ceramide phosphoethanolamine synthase isoform X1
uncharacterized protein LOC110995871 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phospholipid phosphatase 6, transcript variant X2
phospholipid phosphatase 6, transcript variant X3
phospholipid phosphatase 6, transcript variant X1
uncharacterized LOC110997783, transcript variant X2
uncharacterized LOC110997783, transcript variant X1
uncharacterized protein LOC110997783 isoform X2
uncharacterized protein LOC110997783 isoform X1
uncharacterized LOC110995862, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC110995862, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC110995862 isoform X1
uncharacterized protein LOC110995862 isoform X2
uncharacterized LOC110995866, transcript variant X2
uncharacterized LOC110995866, transcript variant X1
NUAK family SNF1-like kinase 1, transcript variant X5
NUAK family SNF1-like kinase 1, transcript variant X1
NUAK family SNF1-like kinase 1, transcript variant X6
NUAK family SNF1-like kinase 1, transcript variant X7
NUAK family SNF1-like kinase 1, transcript variant X2
NUAK family SNF1-like kinase 1, transcript variant X8
NUAK family SNF1-like kinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
NUAK family SNF1-like kinase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NUAK family SNF1-like kinase 1, transcript variant X10
NUAK family SNF1-like kinase 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase par-1 isoform X5
NUAK family SNF1-like kinase 1 isoform X7
uncharacterized protein LOC110995887 isoform X1
uncharacterized protein LOC110995887 isoform X2
serine/threonine-protein kinase par-1 isoform X4
NUAK family SNF1-like kinase 1 isoform X6
NUAK family SNF1-like kinase 1 isoform X8
NUAK family SNF1-like kinase 1 isoform X9
NUAK family SNF1-like kinase 1 isoform X10
NUAK family SNF1-like kinase 1, transcript variant X3
muscle M-line assembly protein unc-89 isoform X3
dipeptidyl peptidase 3, transcript variant X2
dipeptidyl peptidase 3, transcript variant X1
rho GTPase-activating protein 39, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
rho GTPase-activating protein 39, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
rho GTPase-activating protein 39, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
rho GTPase-activating protein 39 isoform X1
rho GTPase-activating protein 39 isoform X3
rho GTPase-activating protein 39 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
polypyrimidine tract-binding protein 2, transcript variant X3
polypyrimidine tract-binding protein 2, transcript variant X4
polypyrimidine tract-binding protein 2, transcript variant X7
polypyrimidine tract-binding protein 2 isoform X3
polypyrimidine tract-binding protein 2 isoform X4
polypyrimidine tract-binding protein 2 isoform X7
polypyrimidine tract-binding protein 2, transcript variant X5
polypyrimidine tract-binding protein 2 isoform X5
polypyrimidine tract-binding protein 2, transcript variant X6
polypyrimidine tract-binding protein 2, transcript variant X1
polypyrimidine tract-binding protein 2 isoform X1
polypyrimidine tract-binding protein 2 isoform X6
polypyrimidine tract-binding protein 2, transcript variant X2
polypyrimidine tract-binding protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X2
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X4
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X1
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X3
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X6
2-oxoglutarate dehydrogenase, mitochondrial, transcript variant X5
2-oxoglutarate dehydrogenase, mitochondrial isoform X5
2-oxoglutarate dehydrogenase, mitochondrial isoform X3
2-oxoglutarate dehydrogenase, mitochondrial isoform X4
2-oxoglutarate dehydrogenase, mitochondrial isoform X1
2-oxoglutarate dehydrogenase, mitochondrial isoform X2
calcium uptake protein 1 homolog, mitochondrial, transcript variant X1
calcium uptake protein 1 homolog, mitochondrial, transcript variant X2
calcium uptake protein 1 homolog, mitochondrial isoform X1
calcium uptake protein 1 homolog, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PDZ and LIM domain protein 3, transcript variant X2
uncharacterized protein LOC110998372 isoform X2
PDZ and LIM domain protein 3, transcript variant X6
PDZ and LIM domain protein 3, transcript variant X1
PDZ and LIM domain protein 3, transcript variant X3
PDZ and LIM domain protein 3, transcript variant X4
PDZ and LIM domain protein 3, transcript variant X5
nucleolar protein dao-5, transcript variant X2
nucleolar protein dao-5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
PDZ and LIM domain protein Zasp, transcript variant X2
PDZ and LIM domain protein Zasp, transcript variant X5
PDZ and LIM domain protein Zasp, transcript variant X3
PDZ and LIM domain protein Zasp, transcript variant X1
PDZ and LIM domain protein Zasp, transcript variant X4
PDZ and LIM domain protein Zasp, transcript variant X6
PDZ and LIM domain protein Zasp, transcript variant X7
PDZ and LIM domain protein Zasp, transcript variant X9
PDZ and LIM domain protein Zasp, transcript variant X8
PDZ and LIM domain protein Zasp, transcript variant X11
PDZ and LIM domain protein Zasp, transcript variant X10
PDZ and LIM domain protein Zasp isoform X2
PDZ and LIM domain protein Zasp isoform X9
PDZ and LIM domain protein Zasp isoform X5
PDZ and LIM domain protein Zasp isoform X7
PDZ and LIM domain protein Zasp isoform X3
PDZ and LIM domain protein Zasp isoform X1
PDZ and LIM domain protein Zasp isoform X8
PDZ and LIM domain protein Zasp isoform X4
PDZ and LIM domain protein Zasp isoform X6
PDZ and LIM domain protein Zasp isoform X11
PDZ and LIM domain protein Zasp isoform X10
iron-sulfur cluster assembly 1 homolog, mitochondrial, transcript variant X1
iron-sulfur cluster assembly 1 homolog, mitochondrial, transcript variant X2
iron-sulfur cluster assembly 1 homolog, mitochondrial
polyadenylate-binding protein-interacting protein 1
D-2-hydroxyglutarate dehydrogenase, mitochondrial
ribosome biogenesis protein BRX1 homolog
choline transporter-like 1, transcript variant X3
choline transporter-like 1, transcript variant X2
choline transporter-like 1, transcript variant X1
39S ribosomal protein L55, mitochondrial, transcript variant X1
39S ribosomal protein L55, mitochondrial, transcript variant X2
39S ribosomal protein L55, mitochondrial
holocytochrome c-type synthase, transcript variant X1
holocytochrome c-type synthase, transcript variant X2
BRISC and BRCA1-A complex member 2, transcript variant X2
BRISC and BRCA1-A complex member 2, transcript variant X1
BRISC and BRCA1-A complex member 2 isoform X2
BRISC and BRCA1-A complex member 2 isoform X1
uncharacterized protein YJR142W, transcript variant X1
uncharacterized protein YJR142W, transcript variant X2
uncharacterized protein YJR142W isoform X1
uncharacterized protein YJR142W isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X5
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X6
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X7
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X11
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G isoform X9
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X8
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X10
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X8
serine/threonine-protein kinase Nek8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110998403, transcript variant X4
uncharacterized LOC110998403, transcript variant X5
uncharacterized LOC110998403, transcript variant X3
uncharacterized LOC110998403, transcript variant X1
uncharacterized LOC110998403, transcript variant X2
uncharacterized protein LOC110998403 isoform X3
uncharacterized protein LOC110998403 isoform X4
uncharacterized protein LOC110998403 isoform X2
uncharacterized protein LOC110998403 isoform X1
T-box transcription factor TBX19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
T-box transcription factor TBX19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endocuticle structural glycoprotein SgAbd-8
uncharacterized LOC110998409, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC110998409, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110998409, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
endocuticle structural glycoprotein ABD-4
endocuticle structural glycoprotein ABD-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
endocuticle structural glycoprotein SgAbd-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endocuticle structural glycoprotein ABD-5-like
endocuticle structural glycoprotein SgAbd-5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
endocuticle structural glycoprotein SgAbd-9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein lethal(3)malignant blood neoplasm 1, transcript variant X1
protein lethal(3)malignant blood neoplasm 1 isoform X1
protein lethal(3)malignant blood neoplasm 1, transcript variant X2
protein lethal(3)malignant blood neoplasm 1 isoform X2
putative mediator of RNA polymerase II transcription subunit 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 54 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial
eukaryotic translation initiation factor 3 subunit G
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
general transcription factor IIE subunit 1
tyrosine-protein kinase transmembrane receptor Ror2
putative ATPase N2B, transcript variant X1
putative ATPase N2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 19, transcript variant X1
zinc finger protein 19, transcript variant X3
zinc finger protein 19, transcript variant X2
tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like, transcript variant X1
tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like, transcript variant X2
tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like isoform X2
uncharacterized LOC110994665, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC110994665, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC110994665, transcript variant X2
uncharacterized LOC110994665, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC110994665 isoform X2
uncharacterized protein LOC110994665 isoform X1
protein still life, isoform SIF type 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein still life, isoform SIF type 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein still life, isoform SIF type 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein still life, isoform SIF type 1, transcript variant X4
protein still life, isoform SIF type 1, transcript variant X6
protein still life, isoform SIF type 1, transcript variant X5
protein still life, isoform SIF type 1, transcript variant X3
protein still life, isoform SIF type 1, transcript variant X7
protein still life, isoform SIF type 1, transcript variant X2
protein still life, isoform SIF type 1 isoform X8
protein still life, isoform SIF type 1 isoform X10
protein still life, isoform SIF type 1 isoform X1
protein still life, isoform SIF type 1 isoform X4
protein still life, isoform SIF type 1 isoform X6
protein still life, isoform SIF type 1 isoform X5
protein still life, isoform SIF type 1 isoform X3
protein still life, isoform SIF type 1 isoform X7
protein still life, isoform SIF type 1 isoform X2
protein still life, isoform SIF type 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5
nuclear migration protein nudC, transcript variant X1
nuclear migration protein nudC, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protocadherin Fat 4, transcript variant X1
protocadherin Fat 4, transcript variant X2
uncharacterized protein LOC110994652 isoform X1
collagen alpha-1(III) chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
collagen alpha-1(III) chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
collagen alpha-1(III) chain, transcript variant X2
peptidyl-prolyl cis-trans isomerase G, transcript variant X2
peptidyl-prolyl cis-trans isomerase G, transcript variant X3
peptidyl-prolyl cis-trans isomerase G, transcript variant X1
peptidyl-prolyl cis-trans isomerase G, transcript variant X4
serine/arginine repetitive matrix protein 1 isoform X2
serine/arginine repetitive matrix protein 1 isoform X3
serine/arginine repetitive matrix protein 1 isoform X1
peptidyl-prolyl cis-trans isomerase G isoform X4
phosphoribosylformylglycinamidine synthase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 114 samples with support for all annotated introns
glycine dehydrogenase (decarboxylating), mitochondrial
TBC1 domain family member 30, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family member 30, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC111000404 isoform X1
uncharacterized protein LOC111000404 isoform X2
TBC1 domain family member 30, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tissue inhibitor of metalloproteinase, transcript variant X1
tissue inhibitor of metalloproteinase, transcript variant X2
uncharacterized LOC110998518, transcript variant X1
uncharacterized LOC110998518, transcript variant X2
uncharacterized protein LOC110998518 isoform X1
uncharacterized protein LOC110998518 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor A2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 91 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
constitutive coactivator of PPAR-gamma-like protein 1 homolog, transcript variant X1
constitutive coactivator of PPAR-gamma-like protein 1 homolog, transcript variant X2
constitutive coactivator of PPAR-gamma-like protein 1 homolog isoform X1
constitutive coactivator of PPAR-gamma-like protein 1 homolog isoform X2
GPN-loop GTPase 2, transcript variant X2
GPN-loop GTPase 2, transcript variant X1
rhodanese domain-containing protein CG4456-like, transcript variant X2
rhodanese domain-containing protein CG4456-like, transcript variant X1
rhodanese domain-containing protein CG4456-like isoform X2
rhodanese domain-containing protein CG4456-like isoform X1
beta-1,3-galactosyltransferase 2, transcript variant X2
beta-1,3-galactosyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
39S ribosomal protein L20, mitochondrial
pancreatic triacylglycerol lipase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pancreatic triacylglycerol lipase, transcript variant X1
pancreatic triacylglycerol lipase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pancreatic triacylglycerol lipase isoform X2
pancreatic triacylglycerol lipase isoform X1
pancreatic triacylglycerol lipase isoform X3
translation initiation factor eIF-2B subunit gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidate cytidylyltransferase, mitochondrial
uncharacterized LOC110998481, transcript variant X2
uncharacterized LOC110998481, transcript variant X3
uncharacterized LOC110998481, transcript variant X1
uncharacterized protein LOC110998481 isoform X2
uncharacterized protein LOC110998481 isoform X1
GTP:AMP phosphotransferase AK3, mitochondrial
uncharacterized LOC110998482, transcript variant X1
uncharacterized protein LOC110998482 isoform X1
uncharacterized LOC110998482, transcript variant X2
uncharacterized protein LOC110998482 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
MFS-type transporter SLC18B1, transcript variant X2
MFS-type transporter SLC18B1, transcript variant X1
eukaryotic translation initiation factor 2A
armadillo repeat-containing protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
armadillo repeat-containing protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
armadillo repeat-containing protein 7 isoform X1
armadillo repeat-containing protein 7 isoform X2
protein tramtrack, alpha isoform, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein tramtrack, alpha isoform, transcript variant X1
protein tramtrack, alpha isoform, transcript variant X6
protein tramtrack, alpha isoform, transcript variant X5
protein tramtrack, alpha isoform, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tramtrack, alpha isoform, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tramtrack, beta isoform isoform X1
protein tramtrack, alpha isoform isoform X3
protein tramtrack, beta isoform isoform X2
uncharacterized LOC110998489, transcript variant X1
uncharacterized LOC110998489, transcript variant X2
uncharacterized LOC110998489, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger Ran-binding domain-containing protein 2, transcript variant X2
zinc finger Ran-binding domain-containing protein 2, transcript variant X1
zinc finger Ran-binding domain-containing protein 2 isoform X2
uncharacterized protein LOC111001180 isoform X1
prenylated Rab acceptor protein 1, transcript variant X1
prenylated Rab acceptor protein 1, transcript variant X2
prenylated Rab acceptor protein 1 isoform X1
prenylated Rab acceptor protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 91 samples with support for all annotated introns
TLD domain-containing protein 2, transcript variant X17
TLD domain-containing protein 2, transcript variant X10
TLD domain-containing protein 2, transcript variant X8
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2, transcript variant X2
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X15
TLD domain-containing protein 2, transcript variant X16
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X3
TLD domain-containing protein 2, transcript variant X12
TLD domain-containing protein 2, transcript variant X14
TLD domain-containing protein 2, transcript variant X13
oxidation resistance protein 1 isoform X14
oxidation resistance protein 1 isoform X7
oxidation resistance protein 1 isoform X6
nuclear receptor coactivator 7 isoform X8
oxidation resistance protein 1 isoform X5
oxidation resistance protein 1 isoform X2
nuclear receptor coactivator 7 isoform X13
nuclear receptor coactivator 7 isoform X4
nuclear receptor coactivator 7 isoform X3
nuclear receptor coactivator 7 isoform X1
oxidation resistance protein 1 isoform X12
nuclear receptor coactivator 7 isoform X9
TLD domain-containing protein 2 isoform X11
TLD domain-containing protein 2 isoform X10
ankyrin repeat domain-containing protein 13C
coiled-coil domain-containing protein 39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 91, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 91, transcript variant X4
zinc finger protein 91, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger protein 91, transcript variant X1
PR domain zinc finger protein 15 isoform X2
PR domain zinc finger protein 15 isoform X3
E3 ubiquitin-protein ligase TRIP12, transcript variant X1
E3 ubiquitin-protein ligase TRIP12, transcript variant X5
E3 ubiquitin-protein ligase TRIP12, transcript variant X7
E3 ubiquitin-protein ligase TRIP12, transcript variant X3
E3 ubiquitin-protein ligase TRIP12, transcript variant X6
E3 ubiquitin-protein ligase TRIP12, transcript variant X4
E3 ubiquitin-protein ligase TRIP12, transcript variant X2
E3 ubiquitin-protein ligase TRIP12 isoform X1
E3 ubiquitin-protein ligase TRIP12 isoform X4
E3 ubiquitin-protein ligase TRIP12 isoform X6
E3 ubiquitin-protein ligase TRIP12 isoform X2
E3 ubiquitin-protein ligase TRIP12 isoform X5
E3 ubiquitin-protein ligase TRIP12 isoform X3
inter-alpha-trypsin inhibitor heavy chain H4, transcript variant X2
inter-alpha-trypsin inhibitor heavy chain H4, transcript variant X4
inter-alpha-trypsin inhibitor heavy chain H4, transcript variant X3
inter-alpha-trypsin inhibitor heavy chain H4, transcript variant X1
inter-alpha-trypsin inhibitor heavy chain H4 isoform X2
inter-alpha-trypsin inhibitor heavy chain H4 isoform X4
inter-alpha-trypsin inhibitor heavy chain H4 isoform X3
inter-alpha-trypsin inhibitor heavy chain H4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial DNA helicase, transcript variant X2
mitochondrial DNA helicase, transcript variant X1
mediator of RNA polymerase II transcription subunit 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12, transcript variant X2
mediator of RNA polymerase II transcription subunit 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12 isoform X1
mediator of RNA polymerase II transcription subunit 12 isoform X3
mediator of RNA polymerase II transcription subunit 12 isoform X5
mediator of RNA polymerase II transcription subunit 12 isoform X2
mediator of RNA polymerase II transcription subunit 12 isoform X4
zinc finger protein 665, transcript variant X3
zinc finger protein 665, transcript variant X1
zinc finger protein 665, transcript variant X2
endothelial differentiation-related factor 1 homolog
2-oxoglutarate-dependent dioxygenase htyE
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
collagen alpha-1(I) chain, transcript variant X2
collagen alpha-1(I) chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kynurenine formamidase, transcript variant X2
kynurenine formamidase, transcript variant X3
kynurenine formamidase, transcript variant X1
uncharacterized protein DDB_G0286299-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase-like 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
formin-binding protein 1-like, transcript variant X2
formin-binding protein 1-like, transcript variant X1
formin-binding protein 1-like, transcript variant X3
formin-binding protein 1-like, transcript variant X4
formin-binding protein 1-like isoform X1
formin-binding protein 1-like isoform X2
formin-binding protein 1-like isoform X3
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone], transcript variant X1
glucose dehydrogenase [FAD, quinone], transcript variant X2
39S ribosomal protein L51, mitochondrial, transcript variant X3
39S ribosomal protein L51, mitochondrial, transcript variant X2
39S ribosomal protein L51, mitochondrial, transcript variant X1
39S ribosomal protein L51, mitochondrial
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial
zinc finger protein 135, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
zinc finger protein 135, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC110993727 isoform X2
bromodomain-containing protein 3, transcript variant X1
bromodomain-containing protein 3, transcript variant X6
bromodomain-containing protein 3, transcript variant X3
bromodomain-containing protein 3, transcript variant X2
bromodomain-containing protein 3, transcript variant X5
bromodomain-containing protein 3, transcript variant X7
bromodomain-containing protein 3, transcript variant X4
bromodomain-containing protein 3 isoform X4
bromodomain-containing protein 3 isoform X1
bromodomain-containing protein 3 isoform X3
bromodomain-containing protein 3 isoform X2
bromodomain-containing protein 3 isoform X5
bromodomain-containing protein 3 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat-containing protein 57
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, transcript variant X3
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, transcript variant X2
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, transcript variant X4
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha isoform X2
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha
1-acyl-sn-glycerol-3-phosphate acyltransferase beta, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase beta, transcript variant X2
1-acyl-sn-glycerol-3-phosphate acyltransferase beta isoform X2
1-acyl-sn-glycerol-3-phosphate acyltransferase beta isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
gamma-aminobutyric acid type B receptor subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type B receptor subunit 1 isoform X2
gamma-aminobutyric acid type B receptor subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type B receptor subunit 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative lipoyltransferase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
NADPH:adrenodoxin oxidoreductase, mitochondrial-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NADPH:adrenodoxin oxidoreductase, mitochondrial-like
mitochondrial-processing peptidase subunit alpha
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
guanine nucleotide-releasing factor 2, transcript variant X6
guanine nucleotide-releasing factor 2 isoform X6
guanine nucleotide-releasing factor 2, transcript variant X1
guanine nucleotide-releasing factor 2, transcript variant X2
guanine nucleotide-releasing factor 2, transcript variant X3
guanine nucleotide-releasing factor 2, transcript variant X4
guanine nucleotide-releasing factor 2 isoform X1
guanine nucleotide-releasing factor 2 isoform X2
guanine nucleotide-releasing factor 2 isoform X3
guanine nucleotide-releasing factor 2 isoform X4
guanine nucleotide-releasing factor 2, transcript variant X5
guanine nucleotide-releasing factor 2 isoform X5
guanine nucleotide-releasing factor 2, transcript variant X7
guanine nucleotide-releasing factor 2 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
U4/U6.U5 tri-snRNP-associated protein 2, transcript variant X3
U4/U6.U5 tri-snRNP-associated protein 2, transcript variant X4
U4/U6.U5 tri-snRNP-associated protein 2, transcript variant X2
U4/U6.U5 tri-snRNP-associated protein 2, transcript variant X1
U4/U6.U5 tri-snRNP-associated protein 2 isoform X1
U4/U6.U5 tri-snRNP-associated protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein obstructor-E, transcript variant X2
protein obstructor-E, transcript variant X1
uncharacterized LOC111001826, transcript variant X1
uncharacterized LOC111001826, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC111001826, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC111001826 isoform X2
uncharacterized protein LOC111001826 isoform X3
uncharacterized protein LOC111001826 isoform X1
voltage-dependent calcium channel type A subunit alpha-1, transcript variant X2
voltage-dependent calcium channel type A subunit alpha-1, transcript variant X1
voltage-dependent calcium channel type A subunit alpha-1, transcript variant X4
voltage-dependent calcium channel type A subunit alpha-1, transcript variant X3
voltage-dependent calcium channel type A subunit alpha-1 isoform X2
voltage-dependent calcium channel type A subunit alpha-1 isoform X1
voltage-dependent calcium channel type A subunit alpha-1 isoform X4
voltage-dependent calcium channel type A subunit alpha-1 isoform X3
PDZ domain-containing protein 8, transcript variant X2
PDZ domain-containing protein 8, transcript variant X5
PDZ domain-containing protein 8, transcript variant X4
PDZ domain-containing protein 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PDZ domain-containing protein 8, transcript variant X1
PDZ domain-containing protein 8 isoform X1
PDZ domain-containing protein 8 isoform X2
PDZ domain-containing protein 8 isoform X3
leucine-rich repeat-containing protein 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
leucine-rich repeat-containing protein 57 isoform X1
leucine-rich repeat-containing protein 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
leucine-rich repeat-containing protein 40 isoform X2
probable E3 ubiquitin-protein ligase HERC2
39S ribosomal protein L30, mitochondrial
GTPase-activating Rap/Ran-GAP domain-like protein 3
ZZ-type zinc finger-containing protein 3
coiled-coil domain-containing protein 28A
60 kDa SS-A/Ro ribonucleoprotein, transcript variant X1
60 kDa SS-A/Ro ribonucleoprotein, transcript variant X2
serine/threonine-protein phosphatase 6 catalytic subunit
eukaryotic translation initiation factor 3 subunit I
hormone receptor 4, transcript variant X4
hormone receptor 4, transcript variant X1
hormone receptor 4, transcript variant X3
hormone receptor 4, transcript variant X2
hormone receptor 4, transcript variant X5
hormone receptor 4, transcript variant X6
ras GTPase-activating protein raskol, transcript variant X6
ras GTPase-activating protein raskol, transcript variant X1
ras GTPase-activating protein raskol, transcript variant X2
ras GTPase-activating protein raskol, transcript variant X4
ras GTPase-activating protein raskol, transcript variant X3
ras GTPase-activating protein raskol, transcript variant X11
ras GTPase-activating protein raskol, transcript variant X13
ras GTPase-activating protein raskol, transcript variant X12
ras GTPase-activating protein raskol, transcript variant X10
ras GTPase-activating protein raskol, transcript variant X8
ras GTPase-activating protein raskol, transcript variant X9
ras GTPase-activating protein raskol, transcript variant X7
ras GTPase-activating protein raskol, transcript variant X5
ras GTPase-activating protein raskol isoform X4
ras GTPase-activating protein raskol isoform X2
ras GTPase-activating protein raskol isoform X1
ras GTPase-activating protein raskol isoform X6
ras GTPase-activating protein raskol isoform X5
ras GTPase-activating protein raskol isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 22
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial
protein-associating with the carboxyl-terminal domain of ezrin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein-associating with the carboxyl-terminal domain of ezrin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein-associating with the carboxyl-terminal domain of ezrin isoform X1
protein-associating with the carboxyl-terminal domain of ezrin isoform X2
protein-serine O-palmitoleoyltransferase porcupine
ribosomal RNA small subunit methyltransferase NEP1
mediator of RNA polymerase II transcription subunit 18
choline transporter-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
choline transporter-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
choline transporter-like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 92 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable ATP-dependent RNA helicase CG8611
ATP-binding cassette sub-family F member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC111002024, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
uncharacterized LOC111002024, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized protein LOC111002024 isoform X1
uncharacterized protein LOC111002024 isoform X2
uncharacterized LOC111002024, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC111002024 isoform X3
anaphase-promoting complex subunit 15-like
beta-galactoside alpha-2,6-sialyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X6
matrix metalloproteinase-14, transcript variant X8
matrix metalloproteinase-14, transcript variant X1
matrix metalloproteinase-14, transcript variant X12
matrix metalloproteinase-14, transcript variant X7
matrix metalloproteinase-14, transcript variant X10
matrix metalloproteinase-14, transcript variant X4
matrix metalloproteinase-14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X2
matrix metalloproteinase-14, transcript variant X3
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like
uncharacterized LOC111002080, transcript variant X2
uncharacterized LOC111002080, transcript variant X1
sodium-dependent phosphate transporter 1-A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium-dependent phosphate transporter 1-A
sodium-dependent phosphate transporter 1-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
presenilins-associated rhomboid-like protein, mitochondrial isoform X1
presenilins-associated rhomboid-like protein, mitochondrial isoform X2
S-formylglutathione hydrolase, transcript variant X1
S-formylglutathione hydrolase, transcript variant X2
host cell factor-like, transcript variant X1
host cell factor-like, transcript variant X2
host cell factor-like, transcript variant X3
host cell factor-like, transcript variant X4
regulating synaptic membrane exocytosis protein 2, transcript variant X4
regulating synaptic membrane exocytosis protein 2, transcript variant X3
regulating synaptic membrane exocytosis protein 2, transcript variant X1
regulating synaptic membrane exocytosis protein 2, transcript variant X2
regulating synaptic membrane exocytosis protein 2 isoform X4
regulating synaptic membrane exocytosis protein 2 isoform X3
regulating synaptic membrane exocytosis protein 2 isoform X2
regulating synaptic membrane exocytosis protein 2 isoform X1
regulating synaptic membrane exocytosis protein 2, transcript variant X5
antichymotrypsin-2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
antichymotrypsin-2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
antichymotrypsin-2, transcript variant X2
antichymotrypsin-2, transcript variant X3
antichymotrypsin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
glia-derived nexin, transcript variant X2
glia-derived nexin, transcript variant X1
glia-derived nexin, transcript variant X3
uncharacterized protein LOC111002818 isoform X2
glia-derived nexin, transcript variant X4
acetylcholine receptor subunit alpha-type acr-16-like
small integral membrane protein 8, transcript variant X2
small integral membrane protein 8, transcript variant X1
small integral membrane protein 8, transcript variant X4
small integral membrane protein 8, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
uncharacterized LOC111001868, transcript variant X5
uncharacterized LOC111001868, transcript variant X4
uncharacterized protein LOC111001868 isoform X4
uncharacterized LOC111001868, transcript variant X1
uncharacterized LOC111001868, transcript variant X2
uncharacterized LOC111001868, transcript variant X6
uncharacterized protein LOC111001868 isoform X1
uncharacterized protein LOC111001868 isoform X2
uncharacterized LOC111001868, transcript variant X3
uncharacterized protein LOC111001868 isoform X3
uncharacterized protein LOC111001868 isoform X5
uncharacterized LOC111001868, transcript variant X7
uncharacterized protein LOC111001868 isoform X6
zinc finger CCCH-type with G patch domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
alpha-methylacyl-CoA racemase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
alpha-methylacyl-CoA racemase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 113 samples with support for all annotated introns
alpha-methylacyl-CoA racemase isoform X2
alpha-methylacyl-CoA racemase isoform X1
probable phosphorylase b kinase regulatory subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X6
probable phosphorylase b kinase regulatory subunit beta isoform X2
probable phosphorylase b kinase regulatory subunit beta isoform X3
probable phosphorylase b kinase regulatory subunit beta isoform X1
probable phosphorylase b kinase regulatory subunit beta isoform X4
probable phosphorylase b kinase regulatory subunit beta isoform X5
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X3
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
DNA topoisomerase 1, transcript variant X1
DNA topoisomerase 1, transcript variant X2
DNA topoisomerase I, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like 1, transcript variant X4
ral guanine nucleotide dissociation stimulator-like 1, transcript variant X5
ral guanine nucleotide dissociation stimulator-like 1 isoform X3
ral guanine nucleotide dissociation stimulator-like 1 isoform X4
ral guanine nucleotide dissociation stimulator-like 1, transcript variant X2
ral guanine nucleotide dissociation stimulator-like 1, transcript variant X1
ral guanine nucleotide dissociation stimulator-like 1 isoform X1
ral guanine nucleotide dissociation stimulator-like 1, transcript variant X3
ral guanine nucleotide dissociation stimulator-like 1 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA proline (anticodon CGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
metallophosphoesterase 1 homolog, transcript variant X1
metallophosphoesterase 1 homolog, transcript variant X2
metallophosphoesterase 1 homolog, transcript variant X3
metallophosphoesterase 1 homolog isoform X2
metallophosphoesterase 1 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC111002284, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC111002284, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC111002284 isoform X1
uncharacterized protein LOC111002284 isoform X2
uncharacterized protein C18orf19 homolog A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB2
piezo-type mechanosensitive ion channel component, transcript variant X7
piezo-type mechanosensitive ion channel component, transcript variant X8
piezo-type mechanosensitive ion channel component, transcript variant X6
piezo-type mechanosensitive ion channel component, transcript variant X11
piezo-type mechanosensitive ion channel component, transcript variant X5
piezo-type mechanosensitive ion channel component, transcript variant X9
piezo-type mechanosensitive ion channel component, transcript variant X10
piezo-type mechanosensitive ion channel component, transcript variant X4
piezo-type mechanosensitive ion channel component, transcript variant X3
piezo-type mechanosensitive ion channel component, transcript variant X2
piezo-type mechanosensitive ion channel component, transcript variant X1
piezo-type mechanosensitive ion channel component, transcript variant X12
piezo-type mechanosensitive ion channel component isoform X5
piezo-type mechanosensitive ion channel component isoform X6
piezo-type mechanosensitive ion channel component isoform X4
piezo-type mechanosensitive ion channel component isoform X9
piezo-type mechanosensitive ion channel component isoform X3
piezo-type mechanosensitive ion channel component isoform X7
piezo-type mechanosensitive ion channel component isoform X8
piezo-type mechanosensitive ion channel component isoform X2
piezo-type mechanosensitive ion channel component isoform X1
piezo-type mechanosensitive ion channel component isoform X10
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X2
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X4
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X5
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X3
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X1
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X3
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X4
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X5
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC111002148, transcript variant X1
uncharacterized protein LOC111002148 isoform X1
uncharacterized LOC111002148, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC111002148 isoform X2
secretion-regulating guanine nucleotide exchange factor, transcript variant X2
secretion-regulating guanine nucleotide exchange factor, transcript variant X1
secretion-regulating guanine nucleotide exchange factor isoform X1
secretion-regulating guanine nucleotide exchange factor isoform X2
coiled-coil domain-containing protein 43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
class E basic helix-loop-helix protein 22-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor-like protein
alpha-tocopherol transfer protein, transcript variant X4
alpha-tocopherol transfer protein, transcript variant X2
alpha-tocopherol transfer protein, transcript variant X3
alpha-tocopherol transfer protein, transcript variant X1
alpha-tocopherol transfer protein isoform X2
alpha-tocopherol transfer protein isoform X3
alpha-tocopherol transfer protein isoform X1
alpha-tocopherol transfer protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
general transcription factor 3C polypeptide 5
asparagine synthetase domain-containing protein CG17486, transcript variant X1
asparagine synthetase domain-containing protein CG17486, transcript variant X2
asparagine synthetase domain-containing protein CG17486 isoform X1
asparagine synthetase domain-containing protein CG17486 isoform X2
asparagine synthetase domain-containing protein CG17486, transcript variant X3
asparagine synthetase domain-containing protein CG17486 isoform X3
arf-GAP domain and FG repeat-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rab3 GTPase-activating protein catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
leucine-rich repeat and fibronectin type III domain-containing protein 1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable G-protein coupled receptor 158, transcript variant X1
probable G-protein coupled receptor 158, transcript variant X2
probable G-protein coupled receptor 158 isoform X1
probable G-protein coupled receptor 158 isoform X2
cytosolic carboxypeptidase 6, transcript variant X1
cytosolic carboxypeptidase 6, transcript variant X2
TATA box-binding protein-like 1, transcript variant X1
TATA box-binding protein-like 1, transcript variant X2
villin-like protein quail, transcript variant X2
villin-like protein quail, transcript variant X1
elongation factor Ts, mitochondrial, transcript variant X4
elongation factor Ts, mitochondrial, transcript variant X3
elongation factor Ts, mitochondrial, transcript variant X1
elongation factor Ts, mitochondrial, transcript variant X2
elongation factor Ts, mitochondrial, transcript variant X5
elongation factor Ts, mitochondrial isoform X1
elongation factor Ts, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
chaetoglobosin A biosynthesis cluster protein C, transcript variant X3
chaetoglobosin A biosynthesis cluster protein C, transcript variant X1
chaetoglobosin A biosynthesis cluster protein C isoform X1
chaetoglobosin A biosynthesis cluster protein C, transcript variant X2
chaetoglobosin A biosynthesis cluster protein C isoform X2
chaetoglobosin A biosynthesis cluster protein C isoform X3
BRCA2-interacting transcriptional repressor EMSY, transcript variant X1
BRCA2-interacting transcriptional repressor EMSY, transcript variant X2
BRCA2-interacting transcriptional repressor EMSY isoform X1
BRCA2-interacting transcriptional repressor EMSY isoform X2
aspartate aminotransferase, mitochondrial
WD repeat and FYVE domain-containing protein 2
DNA excision repair protein ERCC-5 homolog, transcript variant X1
DNA excision repair protein ERCC-5 homolog isoform X1
DNA excision repair protein ERCC-5 homolog, transcript variant X2
DNA excision repair protein ERCC-5 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
venom serine carboxypeptidase, transcript variant X3
venom serine carboxypeptidase isoform X3
venom serine carboxypeptidase, transcript variant X1
venom serine carboxypeptidase, transcript variant X2
venom serine carboxypeptidase isoform X1
venom serine carboxypeptidase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 196 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: acyl-CoA Delta(11) desaturase-like
acyl-CoA Delta(11) desaturase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 191 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA Delta(11) desaturase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 191 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
secreted protein C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
secreted protein C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
glutathione hydrolase 6, transcript variant X1
glutathione hydrolase 6, transcript variant X2
zinc finger protein chinmo, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein chinmo, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
larval/pupal rigid cuticle protein 66-like
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1, transcript variant X1
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1, transcript variant X2
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 isoform X1
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1, transcript variant X3
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
intraflagellar transport protein 80 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein-glucosylgalactosylhydroxylysine glucosidase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
transcription factor Sp4, transcript variant X3
transcription factor Sp4, transcript variant X2
transcription factor Sp4, transcript variant X1
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X2
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X4
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X1
glycerol-3-phosphate dehydrogenase, mitochondrial, transcript variant X3
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X1
glycerol-3-phosphate dehydrogenase, mitochondrial isoform X2
probable histone-lysine N-methyltransferase CG1716, transcript variant X1
probable histone-lysine N-methyltransferase CG1716, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable histone-lysine N-methyltransferase CG1716 isoform X1
histone-lysine N-methyltransferase SETD2 isoform X2
outer dynein arm-docking complex subunit 4
cyclic nucleotide-gated cation channel beta-3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 4, transcript variant X3
long-chain-fatty-acid--CoA ligase 4, transcript variant X2
long-chain-fatty-acid--CoA ligase 4, transcript variant X1
long-chain-fatty-acid--CoA ligase 4 isoform X2
long-chain-fatty-acid--CoA ligase 4 isoform X1
sentrin-specific protease 1, transcript variant X1
sentrin-specific protease 1, transcript variant X2
uncharacterized LOC110997842, transcript variant X1
uncharacterized protein LOC110997842 isoform X1
uncharacterized LOC110997842, transcript variant X2
uncharacterized protein LOC110997842 isoform X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X4
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X3
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X5
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X14
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X8
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X23
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X15
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X10
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X9
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X12
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X11
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X6
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X7
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X13
voltage-dependent L-type calcium channel subunit beta-4 isoform X4
voltage-dependent L-type calcium channel subunit beta-3 isoform X3
voltage-dependent L-type calcium channel subunit beta-3 isoform X5
voltage-dependent L-type calcium channel subunit beta-1 isoform X1
voltage-dependent L-type calcium channel subunit beta-1 isoform X2
voltage-dependent L-type calcium channel subunit beta-2 isoform X8
voltage-dependent L-type calcium channel subunit beta-2 isoform X17
voltage-dependent L-type calcium channel subunit beta-2 isoform X12
voltage-dependent L-type calcium channel subunit beta-2 isoform X10
voltage-dependent L-type calcium channel subunit beta-2 isoform X9
voltage-dependent L-type calcium channel subunit beta-2 isoform X7
voltage-dependent L-type calcium channel subunit beta-2 isoform X6
voltage-dependent L-type calcium channel subunit beta-2 isoform X11
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X19
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X18
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X21
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X16
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X20
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X22
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X17
voltage-dependent L-type calcium channel subunit beta-2 isoform X14
voltage-dependent L-type calcium channel subunit beta-2 isoform X16
voltage-dependent L-type calcium channel subunit beta-2 isoform X13
voltage-dependent L-type calcium channel subunit beta-2 isoform X15
transmembrane protein KIAA1109, transcript variant X3
transmembrane protein KIAA1109, transcript variant X2
transmembrane protein KIAA1109, transcript variant X1
transmembrane protein KIAA1109 isoform X3
transmembrane protein KIAA1109 isoform X2
transmembrane protein KIAA1109 isoform X1
cilia- and flagella-associated protein 43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylinositol-glycan biosynthesis class W protein
uncharacterized LOC110996683, transcript variant X2
uncharacterized LOC110996683, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC110996683 isoform X1
uncharacterized protein LOC110996683 isoform X2
G2/mitotic-specific cyclin-B3, transcript variant X3
G2/mitotic-specific cyclin-B3, transcript variant X2
G2/mitotic-specific cyclin-B3, transcript variant X1
G2/mitotic-specific cyclin-B3 isoform X3
G2/mitotic-specific cyclin-B3 isoform X2
G2/mitotic-specific cyclin-B3 isoform X1
peroxisome biogenesis factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
peroxisome biogenesis factor 1, transcript variant X1
peroxisome biogenesis factor 1 isoform X1
peroxisome biogenesis factor 1 isoform X2
transcription factor SOX-14, transcript variant X2
transcription factor SOX-14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcium homeostasis endoplasmic reticulum protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
slit homolog 3 protein, transcript variant X2
slit homolog 3 protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
slit homolog 3 protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
translationally-controlled tumor protein homolog
zinc finger protein 37, transcript variant X1
zinc finger protein 37, transcript variant X2
zinc finger protein 37, transcript variant X3
tyrosine-protein phosphatase non-receptor type 23, transcript variant X2
tyrosine-protein phosphatase non-receptor type 23, transcript variant X1
tyrosine-protein phosphatase non-receptor type 23 isoform X2
tyrosine-protein phosphatase non-receptor type 23 isoform X1
U11/U12 small nuclear ribonucleoprotein 25 kDa protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
LOW QUALITY PROTEIN: U11/U12 small nuclear ribonucleoprotein 25 kDa protein-like
mitochondrial import inner membrane translocase subunit Tim13-like
cytochrome b-c1 complex subunit Rieske, mitochondrial